Related Experiment Video
Updated: Aug 25, 2026
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 15, 2014
Biomarkers of chronic inflammatory state in uremia and cardiovascular disease
Vincenzo Panichi1, Alessia Scatena, Massimiliano Migliori
1Nephrology and Dialysis Unit, Versilia Hospital, Via Aurelia 335, 55034 Lido di Camaiore, Italy.
Insights
Chronic inflammation plays a key role in cardiovascular disease (CVD) risk, especially in kidney disease patients. New markers like CD40-CD40 ligand and pentraxin-3 show promise for predicting CVD events.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Inflammation Research
Background:
- Cardiovascular disease (CVD) is a leading cause of death globally.
- Traditional risk factors inadequately explain high CVD mortality in uremic populations.
- Chronic inflammation is increasingly recognized in atherosclerotic and CVD development.
Purpose of the Study:
- To explore the role of inflammation in cardiovascular disease (CVD).
- To evaluate traditional and nontraditional inflammatory markers for CVD risk prediction.
- To assess the significance of novel markers in the End-Stage Renal Disease (ESRD) population.
Main Methods:
- Review of existing literature on inflammation and CVD.
- Analysis of traditional inflammatory biomarkers (e.g., C-reactive protein, interleukin-6).
- Investigation of emerging nontraditional markers (e.g., CD40-CD40 ligand, pentraxin-3).
Main Results:
- Traditional inflammatory markers (CRP, IL-6) predict CVD events in general and uremic populations.
- Nontraditional inflammatory markers are associated with CVD risk in both populations.
- CD40-CD40 ligand system and pentraxin-3 show significance for CVD in ESRD patients.
Conclusions:
- Inflammation is a critical factor in cardiovascular disease (CVD) pathogenesis.
- Nontraditional inflammatory markers offer enhanced CVD risk prediction, particularly in ESRD.
- Further research into novel markers like CD40-CD40 ligand and pentraxin-3 is warranted for clinical application.
Abstract:
Cardiovascular disease is the leading cause of death in the general population; traditional risk factors seem inadequate to explain completely the remarkable prevalence of cardiovascular mortality and morbidity observed in the uremic population. A role for chronic inflammation has been well established in the development of atherosclerotic disease, and, on the basis of these observations, atherosclerosis might be considered an inflammatory disease. Inflammation has been implicated in the etiology of coronary artery disease in the general population, and traditional inflammatory biomarkers such as C-reactive protein (CRP) and interleukin-6 (IL-6) have been shown to predict cardiovascular events in both symptomatic and asymptomatic individuals as well as those in the uremic population. Later on, new nontraditional markers were related to the risk of cardiovascular morbidity and mortality in general and in uremic population. As a consequence of the expanding research base and availability of assays, the number of inflammatory marker tests ordered by clinicians for cardiovascular disease (CVD) risk prediction has grown rapidly and several commercial assays have become available. So, up to now we can consider that several new nontraditional markers as CD40-CD40 ligand system and pentraxin-3 seem to be significant features of cardiovascular disease in general and in ESRD population.
Related Concept Videos
01:25Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:24Serum Studies: Renal Function Tests
01:25Chronic Kidney Disease I: Introduction
01:24Chronic Kidney Disease II: Clinical Manifestations